Skip to main content
Fig. 8 | Cancer Cell International

Fig. 8

From: Identification of a new gene signature for prognostic evaluation in cervical cancer: based on cuproptosis-associated angiogenesis and multi-omics analysis

Fig. 8

SFT2D1 was involved in the progression of cervical cancer. (A) SFT2D1 and CD31 were highly expressed in cervical cancer by IHC. (B) Correlation analysis between SFT2D1 and CD31. (C) Validation of SFT2D1 expression by RT-qPCR. (D) Validation of SFT2D1 expression by western blotting. Four siRNAs suppressed the expression of SFT2D1 in SiHa (E)and CaSki (F) cells by RT-qPCR. CCK-8 assay in in SiHa (G) and CaSki (H) cells. Wound scratch assay in SiHa (I) and CaSki (J) cells. Transwell assay in SiHa (K) and CaSki (L) cells

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us